An Exploratory Phase II Study of Eribulin Re-challenge After Short Term Therapy of 5-Fluorouracil for HER2 Negative, Advanced or Recurrent Breast Cancer

TSUTOMU TAKASHIMA; SHIGEHIKO NISHIMURA; HIDEMI KAWAJIRI; YOKO MIZUYAMA; TAKEO NISHIMORI; SHIGEHITO YAMAGATA; SHINYA TOKUNAGA; KENJI TEZUKA; SEIKA TEI; TAKESHI SUNAMI; KATSUMI IKEDA; YOSHINARI OGAWA; SHINICHIRO KASHIWAGI; SATORU NODA; NAOYOSHI ONODA; TETSURO ISHIKAWA; SHINZOH KUDOH; MINORU TAKADA; KOSEI HIRAKAWA; MASAICHI OHIRA

doi:10.21873/anticanres.15315

An Exploratory Phase II Study of Eribulin Re-challenge After Short Term Therapy of 5-Fluorouracil for HER2 Negative, Advanced or Recurrent Breast Cancer

Anticancer Research ◽

10.21873/anticanres.15315 ◽

2021 ◽

Vol 41 (10) ◽

pp. 5007-5014

Author(s):

TSUTOMU TAKASHIMA ◽

SHIGEHIKO NISHIMURA ◽

HIDEMI KAWAJIRI ◽

YOKO MIZUYAMA ◽

TAKEO NISHIMORI ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Recurrent Breast Cancer ◽

Term Therapy ◽

Short Term ◽

Short Term Therapy ◽

Recurrent Breast

Download Full-text

An exploratory phase II study of Eribulin re-challenge after short term therapy of 5-fuluorouracil for HER2-negative, advanced or recurrent breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(20)30693-6 ◽

2020 ◽

Vol 138 ◽

pp. S62

Author(s):

T. Takashima ◽

S. Nishimura ◽

H. Kawajiri ◽

Y. Mizuyama ◽

T. Nishimori ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Recurrent Breast Cancer ◽

Term Therapy ◽

Short Term ◽

Short Term Therapy ◽

Recurrent Breast

Download Full-text

Novel strategy to restore the activity of taxanes: A multicenter phase II study of combination therapy with taxanes and toremifene at 120 mg for advanced/recurrent breast cancer—Kinki Multidisciplinary Breast Oncology Group (KMBOG0612).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e13611 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e13611-e13611

Author(s):

T. Nakayama ◽

T. Arai ◽

J. Yamamura ◽

T. Morimoto ◽

Y. Komoike ◽

...

Keyword(s):

Breast Cancer ◽

Combination Therapy ◽

Phase Ii ◽

Phase Ii Study ◽

Recurrent Breast Cancer ◽

Oncology Group ◽

Multicenter Phase ◽

Novel Strategy ◽

Recurrent Breast

Download Full-text

A multicenter phase II study of S-1 combined with irinotecan (CPT-11) for patients with advanced/recurrent breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e11528 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e11528-e11528

Author(s):

U. Toh ◽

N. Iwakuma ◽

H. Otsuka ◽

M. Takenaka ◽

E. Ogo ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Recurrent Breast Cancer ◽

Multicenter Phase ◽

Recurrent Breast

Download Full-text

Phase II study of weekly paclitaxel and carboplatin followed by oral navelbine in patients with triple negative metastatic/recurrent breast cancer previously treated with adjuvant anthracycline and taxotere.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e12557 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e12557-e12557 ◽

Cited By ~ 1

Author(s):

Inas Ibraheim Abdel Halim ◽

Wael El-Sadda ◽

Mostafa El-Ebrashy ◽

Mohamed El Ashry

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Triple Negative ◽

Phase Ii Study ◽

Recurrent Breast Cancer ◽

Weekly Paclitaxel ◽

Previously Treated ◽

Recurrent Breast

Download Full-text

494 Phase II study of S-1 in combination with irinotecan (CPT-11) for patients with advanced/recurrent breast cancer (KSCOG-BC01)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(10)70515-2 ◽

2010 ◽

Vol 8 (3) ◽

pp. 204

Author(s):

U. Toh ◽

T. Fukushima ◽

M. Fukunaga ◽

N. Iwakuma ◽

M. Takenaka ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Recurrent Breast Cancer ◽

Recurrent Breast

Download Full-text

A phase II study of a potent and selective aromatase inhibitor, anastrozole (ZD-1033), in Japanese postmenopausal women with advanced/recurrent breast cancer

European Journal of Cancer ◽

10.1016/s0959-8049(98)80081-6 ◽

1998 ◽

Vol 34 ◽

pp. S21

Author(s):

H. Koyama

Keyword(s):

Breast Cancer ◽

Aromatase Inhibitor ◽

Postmenopausal Women ◽

Phase Ii ◽

Phase Ii Study ◽

Recurrent Breast Cancer ◽

Recurrent Breast

Download Full-text

Novel strategy to restore the activity of taxanes: a multicenter phase II study of combination therapy with taxanes and toremifene at 120 mg for advanced/recurrent breast cancer. (Kinki Multidisciplinary Breast Oncology Group: KMBOG0612)

The Breast ◽

10.1016/j.breast.2011.08.056 ◽

2011 ◽

Vol 20 ◽

pp. S31

Author(s):

Takahiro Nakayama ◽

Takashi Arai ◽

Jun Yamamura ◽

Takashi Morimoto ◽

Yoshifumi Komoike ◽

...

Keyword(s):

Breast Cancer ◽

Combination Therapy ◽

Phase Ii ◽

Phase Ii Study ◽

Recurrent Breast Cancer ◽

Oncology Group ◽

Multicenter Phase ◽

Novel Strategy ◽

Recurrent Breast

Download Full-text

A Multicenter Phase II Study of Docetaxel 60 mg/m2 as First-Line Chemotherapy in Patients with Advanced or Recurrent Breast Cancer

Breast Cancer ◽

10.1007/bf02968045 ◽

2004 ◽

Vol 11 (4) ◽

pp. 374-379 ◽

Cited By ~ 6

Author(s):

Takashi Ishikawa ◽

Satoru Shimizu ◽

Masaaki Inaba ◽

Taro Asaga ◽

Kiyohumi Katayama ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Recurrent Breast Cancer ◽

First Line ◽

Multicenter Phase ◽

Recurrent Breast ◽

Line Chemotherapy

Download Full-text

A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer

British Journal of Cancer ◽

10.1038/bjc.1996.37 ◽

1996 ◽

Vol 73 (2) ◽

pp. 210-216 ◽

Cited By ~ 59

Author(s):

I Adachi ◽

T Watanabe ◽

S Takashima ◽

M Narabayashi ◽

N Horikoshi ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Late Phase ◽

Recurrent Breast Cancer ◽

Recurrent Breast

Download Full-text

A pilot phase II study of capecitabine in advanced or recurrent breast cancer

Breast Cancer ◽

10.2325/jbcs.13.49 ◽

2006 ◽

Vol 13 (1) ◽

pp. 49-57 ◽

Cited By ~ 12

Author(s):

Toshiaki Saeki ◽

Tsunehito Kimura ◽

Masakazu Toi ◽

Tetsuo Taguchi

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Recurrent Breast Cancer ◽

Pilot Phase ◽

Recurrent Breast

Download Full-text